Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations

BACKGROUND: Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an innovative approach based on inhibitors of the mutated BRAF gene (which represents the most prevalent alteration in melanoma patients) appears very promising from the clinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gentilcore, Giusy, Madonna, Gabriele, Mozzillo, Nicola, Ribas, Antoni, Cossu, Antonio, Palmieri, Giuseppe, Ascierto, Paolo A
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Correspondence
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586362/
https://ncbi.nlm.nih.gov/pubmed/23317446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares